temcad TEMOZOLOMIDE

Introduction to temcad

Temcad is a medication primarily used to treat certain aggressive brain tumors, such as glioblastoma multiforme and anaplastic astrocytoma. Temcad is available in tablet form and is a crucial part of cancer treatment regimens.

Composition of temcad

Temcad contains the active ingredient Temozolomide, which belongs to a class of drugs known as alkylating agents. These agents work by adding an alkyl group to the DNA of cancer cells, causing damage that prevents the cells from growing and dividing.

Uses of temcad

• Treatment of glioblastoma multiforme
• Treatment of anaplastic astrocytoma

Side effects of temcad

• Common side effects: nausea, vomiting, fatigue
• Serious side effects: severe bone marrow suppression, increased risk of infection

Precautions of temcad

Patients taking temcad should be aware that it can lower blood cell counts, increasing the risk of infection. It is not recommended for use during pregnancy due to potential harm to the unborn baby. Patients with severe bone marrow suppression should avoid using temcad.

How to Take temcad

Temcad is taken orally, usually as a tablet. The typical starting dose for adults is 150 mg/m² once daily for five days in a 28-day cycle. It should be taken on an empty stomach, either one hour before or two hours after a meal. Always follow your doctor's instructions regarding dosage and administration.

Conclusion of temcad

In conclusion, temcad, with its active ingredient Temozolomide, is a vital medication in the therapeutic class of alkylating agents, used primarily for treating aggressive brain tumors. Manufactured for effective cancer treatment, temcad's key highlights include its mechanism of interfering with cancer cell DNA and its oral administration. Always consult with a healthcare professional for personalized advice and guidance when using temcad.